Possible muscle preserving effect as mentioned above is in accordance with findings of Xiang et al., who examined effect of GLP-1 agonists liraglutide and semaglutide on muscle mass and muscular atrophy in murine models of obesity. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.